Cinfa
SKU: 55410
A medication used to treat high blood pressure by blocking angiotensin II receptors, thereby relaxing blood vessels and reducing the risk of cardiovascular complications.
Indications:
- Treatment of essential hypertension in adults and children, and adolescents aged 6 to less than 18 years.
Main Active Ingredient:
- Olmesartan Medoxomil 40 mg per film-coated tablet.
Precautions:
- Use caution in patients with kidney or liver impairment, heart failure, or on sodium-restricted diets.
- Not recommended during pregnancy due to risk of fetal toxicity; discontinue promptly if pregnancy is detected.
Side Effects:
- Dizziness, headache, fatigue, diarrhea, back pain, respiratory symptoms (e.g., bronchitis, URTI).
- Rare but serious: hyperkalemia, reduced kidney function, allergic reactions.
Drug–Drug Interactions:
- Avoid co-administration with aliskiren in patients with diabetes.
- Use caution when combining with potassium-sparing diuretics, NSAIDs, lithium, certain other antihypertensives, or potassium supplements. (Interaction specifics can vary by product formulation and patient condition.)
Indications:
- Treatment of essential hypertension in adults and children, and adolescents aged 6 to less than 18 years.
Main Active Ingredient:
- Olmesartan Medoxomil 40 mg per film-coated tablet.
Precautions:
- Use caution in patients with kidney or liver impairment, heart failure, or on sodium-restricted diets.
- Not recommended during pregnancy due to risk of fetal toxicity; discontinue promptly if pregnancy is detected.
Side Effects:
- Dizziness, headache, fatigue, diarrhea, back pain, respiratory symptoms (e.g., bronchitis, URTI).
- Rare but serious: hyperkalemia, reduced kidney function, allergic reactions.
Drug–Drug Interactions:
- Avoid co-administration with aliskiren in patients with diabetes.
- Use caution when combining with potassium-sparing diuretics, NSAIDs, lithium, certain other antihypertensives, or potassium supplements. (Interaction specifics can vary by product formulation and patient condition.)
Olmesartan medoxomil, Microcrystalline Cellulose, Lactose Monohydrate, Hydroxypropylcellulose, Low-substituted Hydroxypropylcellulose, Magnesium Stearate; Film coating: Hypromellose, Lactose, Macrogol, Titanium Dioxide (E171)
Recently Viewed